At The One Health Company, our goal is to accelerate the development of successful treatments to save both animal and human lives. We offer enrollment opportunities for different trials. Please use the form below to register your pet with our company. We will contact you at the recruitment stage for a trial that could potentially benefit your pet.
Current Enrollment Opportunities:
Hemangiosarcoma Clinical Trial
We are currently recruiting dogs for a Hemangiosarcoma Trial in partnership with the Johns Hopkins University School of Medicine to evaluate a therapy that potentially could be used to treat cancer in both dogs and humans. The therapy will be evaluated in a clinical study of dogs with Hemangiosarcoma; an aggressive cancer that is sadly very similar to Angiosarcoma, which afflicts humans. The chemotherapeutic medication being used in the study is an Investigational Agent that has been approved by the Food and Drug Administration for the treatment of human patients with a subtype of soft tissue sarcoma. In human studies, the Investigational Agent has demonstrated significant anti-tumor effects including tumor growth inhibition, regression, remission and increased life span for the patient.
For more information please fill out the form below.